Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study.
Clinical trial NCT02101684 · TERMINATED
Trial details
- NCT number
- NCT02101684
- Sponsor
- Grupo Español de Tumores Huérfanos e Infrecuentes
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2017-01-11
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.